Join Brad, Denali, and guest Dan Schell from Clinical Leader for a lively and insightful conversation on the latest trends in clinical research. From the real-world impact of AI and the evolution of site networks to the challenges of technology adoption and industry ethics, this episode dives deep into what's shaping the future of clinical trials. Plus, enjoy some lighthearted banter about cookies and the quirks of the industry. Whether you're a research professional or just curious about the field, this episode offers valuable perspectives and a few laughs along the way!

Join us for a lively episode where we kick things off with tales of catfish, noodling, and regional fishing quirks before diving into the world of clinical research. We discuss the latest cancer center conferences, the persistent challenges facing the industry, and why so many professionals are still relying on spreadsheets and workarounds. Plus, we chat about industry layoffs, the evolving role of CROs, and the reality that sometimes, everyone's just figuring it out as they go.

Laura O'Donnell from GSK challenges the traditional sponsor-site relationship in clinical research. She advocates for treating sites as true customers, not just vendors, by emphasizing transparency, human connection, and meaningful engagement. We dive deep into the challenges sites face, from tech complexity to communication gaps, and explore how the industry can create more collaborative, supportive partnerships that ultimately benefit patients and scientific progress.

Former FDA Commissioner Dr. Robert Califf provides a brutally honest assessment of the current clinical research landscape. He discusses the critical challenges facing medical innovation, from overly complex clinical trials to profit-driven healthcare systems. Dr. Califf offers insights into why clinical research has become increasingly difficult, shares his vision for a more integrated learning health system, and provides hope for researchers and healthcare professionals looking to drive meaningful change. A must-listen for anyone passionate about improving medical research and patient care.

In this electrifying episode, legal experts Darshan Kulkarni and Edye Edens dive deep into the complex world of clinical research. From HIPAA compliance and corporate practice of medicine to the hidden risks facing research sites, they break down critical legal insights with their signature wit and candor. Prepare for an eye-opening conversation that goes beyond the typical industry talk.

In this episode of Note to File, we dive into the recent merger between Circuit and Lightship, explore the behind-the-scenes challenges of clinical research site training, and discuss the ongoing consolidation in the clinical trial industry. Join us for candid insights, industry gossip, and a no-holds-barred conversation about the realities of clinical research.

We discuss National Clinical Trials Day, Mexico's emerging clinical research landscape, and Javara's recent Series C funding. We dive into the challenges of oncology trials, explore the role of venture capital in healthcare, and share some industry gossip about Signant Health's recent job posting for a Director of Reputation and Crisis Communications.

Somehow Note to File has existed for 5 years now....

In this episode we sit down with healthcare veteran Matthew Holt, founder of The Health Care Blog and Health 2.0. Matthew shares his fascinating journey from Stanford grad student to healthcare technology commentator, offering candid insights into digital health, clinical trials, and the challenges of healthcare innovation. From discussing the potential of GLP-1 drugs to exploring the future of longevity research, this conversation provides a witty and insightful look at the evolving landscape of healthcare technology and research.

In this episode of Note to File, we dive deep into the world of clinical research, exploring the challenges of resident physician training, the impact of private equity on clinical trial management systems, and the often-unspoken ethical dilemmas in the field.

Join us as we unpack difficult sponsor behaviors, share hilarious research confessions, and offer candid insights into the clinical research landscape. From PE investments to research sins, this episode is packed with humor, honesty, and hard-hitting discussions that will keep you entertained and informed.

Special Pope election edition.

In this episode, Rohit Nambisan from Lokavant and Jonathan Crowther from Pfizer discuss their innovative approach to clinical trial forecasting. They explore how advanced data analytics and AI can help predict and improve trial operational success, from site selection to protocol design. The conversation delves into reducing uncertainty, enhancing communication between sponsors and sites, and leveraging technology to make clinical research more efficient and patient-focused.